Share on StockTwits

Illumina (NASDAQ:ILMN) Director A Blaine Bowman unloaded 5,000 shares of Illumina stock on the open market in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $171.70, for a total transaction of $858,500.00. Following the completion of the transaction, the director now directly owns 12,722 shares in the company, valued at approximately $2,184,367. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Illumina (NASDAQ:ILMN) traded up 1.45% during mid-day trading on Wednesday, hitting $172.96. The stock had a trading volume of 1,050,723 shares. Illumina has a 1-year low of $72.77 and a 1-year high of $185.00. The stock has a 50-day moving average of $169.8 and a 200-day moving average of $160.4. The company has a market cap of $24.110 billion and a P/E ratio of 113.89.

Illumina (NASDAQ:ILMN) last released its earnings data on Wednesday, July 23rd. The company reported $0.57 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.50 by $0.07. The company had revenue of $448.00 million for the quarter, compared to the consensus estimate of $426.50 million. During the same quarter last year, the company posted $0.43 earnings per share. Illumina’s revenue was up 29.5% compared to the same quarter last year. On average, analysts predict that Illumina will post $2.29 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on ILMN shares. Analysts at Wedbush upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Wednesday. They now have a $200.00 price target on the stock, up previously from $165.00. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Illumina in a research note on Monday, August 11th. They set a “buy” rating and a $200.00 price target on the stock. Finally, analysts at Goldman Sachs raised their price target on shares of Illumina from $184.00 to $187.00 in a research note on Tuesday, August 5th. Four investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $178.92.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.